Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisella Vischini

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Expert Review of Anticancer Therapy|March 23, 2011
Management of hematological malignancies in patients affected by renal failurePasquale Niscola, Gisella Vischini, Andrea Tendas, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2022
Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experienceAndrea De Giglio, Valeria Grandinetti, Marta Aprile, et al.
Kidney International Reports|August 15, 2025
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology DataGiorgio Cazzaniga, Giulia Capitoli, Raffaella Barretta, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Genes|January 26, 2024
DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric CohortValeria Aiello, Francesca Ciurli, Amalia Conti, et al.
Scientific Reports|January 12, 2026
Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathyGiorgio Cazzaniga, Maurizio Carbone, Raffaella Barretta, et al.
Kidney International Reports|May 20, 2024
"Eculizumab First" in the Management of Posttransplant Thrombotic MicroangiopathyFederica Maritati, Valeria Corradetti, Claudia Bini, et al.
Frontiers in Oncology|October 23, 2025
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphomaMarco Talarico, Gisella Vischini, Simona Barbato, et al.
Pathologica|June 14, 2023
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy)Anna Caliò, Antonella Barreca, Stefano Marletta, et al.
Frontiers in Immunology|September 29, 2025
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritisSimeone Andrulli, Lucio Manenti, Francesco Reggiani, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Expert Review of Anticancer Therapy|March 23, 2011
Management of hematological malignancies in patients affected by renal failurePasquale Niscola, Gisella Vischini, Andrea Tendas, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2022
Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experienceAndrea De Giglio, Valeria Grandinetti, Marta Aprile, et al.
Kidney International Reports|August 15, 2025
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology DataGiorgio Cazzaniga, Giulia Capitoli, Raffaella Barretta, et al.
BMC Nephrology|February 13, 2025
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry diseaseGian Marco Berti, Valeria Aiello, Gisella Vischini, et al.
Genes|January 26, 2024
DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric CohortValeria Aiello, Francesca Ciurli, Amalia Conti, et al.
Scientific Reports|January 12, 2026
Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathyGiorgio Cazzaniga, Maurizio Carbone, Raffaella Barretta, et al.
Kidney International Reports|May 20, 2024
"Eculizumab First" in the Management of Posttransplant Thrombotic MicroangiopathyFederica Maritati, Valeria Corradetti, Claudia Bini, et al.
Frontiers in Oncology|October 23, 2025
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphomaMarco Talarico, Gisella Vischini, Simona Barbato, et al.
Pathologica|June 14, 2023
Histology for nephrology, from pre-implantation to post-transplant kidney biopsy. Lesson learned from ReBIrth (Renal BIopsy for Kidney Transplantation Therapy)Anna Caliò, Antonella Barreca, Stefano Marletta, et al.
Frontiers in Immunology|September 29, 2025
Isolated C3 hypocomplementemia as an early predictor of chronic kidney disease in lupus nephritisSimeone Andrulli, Lucio Manenti, Francesco Reggiani, et al.
Pageof 5